Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody.

被引：1
|
作者：
Zelenetz, Andrew David
Mato, Anthony R.
Robak, Tadeusz
Jones, Jeffrey Alan
Pagel, John M.
Barrientos, Jacqueline Claudia
Brown, Jennifer R.
Montillo, Marco
Kipps, Thomas J.
Dubowy, Ronald
Xing, Guan
Li, Julia
Hillmen, Peter
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Hosp Univ Penn, Ctr CLL, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] Med Univ Lodz, Lodz, Poland
[4] Ohio State Univ, Columbus, OH 43210 USA
[5] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[6] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Osped Niguarda Ca Granda, Milan, Italy
[9] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[11] St James Univ Hosp, Leeds, W Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7533
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IDELALISIB PLUS AN ANTI-CD20 ANTIBODY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE HBV CORE ANTIBODY POSITIVE: SIMILAR PATTERNS OF LIVER TEST ABNORMALITIES
    Robak, T.
    Zelenetz, A. D.
    Mato, A.
    Jones, J. A.
    Pagel, J. M.
    Barrientos, J. C.
    Brown, J. R.
    Montillo, M.
    Dubowy, R.
    Xing, G.
    Li, J. J.
    Kipps, T. J.
    Hillmen, P.
    [J]. HAEMATOLOGICA, 2016, 101 : 437 - 437
  • [2] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    [J]. BLOOD, 1999, 94 (10) : 309B - 309B
  • [3] Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.
    Winkler, U
    Jensen, M
    Manzke, O
    Tesch, H
    Bohlen, H
    Diehl, V
    Engert, A
    [J]. BLOOD, 1998, 92 (10) : 285B - 285B
  • [4] Patterns of Lymphocytosis in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Treated with Idelalisib
    Brown, Jennifer R.
    Cheson, Bruce D.
    Furman, Richard R.
    Ghia, Paolo
    Hallek, Michael
    Hillmen, Peter
    O'Brien, Susan M.
    Sharman, Jeff P.
    Dubowy, Ronald L.
    Velasco, Barbara
    Waldapfel, Christopher C.
    Zelenetz, Andrew D.
    [J]. BLOOD, 2015, 126 (23)
  • [5] CHANGES IN SERUM COMPLEMENT ACTIVITY DURING ANTI-CD20 AND ANTI-CD52 MONOCLONAL ANTIBODY THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Stasilojc, Grzegorz
    Felberg, Anna
    Taszner, Michal
    Urban, Aleksandra
    Ma, Shuo
    Blom, Anna
    Lundin, Jeanette
    Osterborg, Anders
    Okroj, Marcin
    [J]. MOLECULAR IMMUNOLOGY, 2019, 114 : 415 - 415
  • [6] Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy
    Hooley, Ian J.
    Chen, Robert
    Maignan, Kathleen
    Carson, Kenneth R.
    [J]. BLOOD, 2018, 132
  • [7] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
    Chuda, Ravindra R.
    Vishnu, Prakash
    Aboulafia, David
    [J]. CURRENT DRUG THERAPY, 2012, 7 (04) : 281 - 289
  • [8] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
    Caitlin M. McNulty
    Emasenyie A. Isikwei
    Pragya Shrestha
    Melissa R. Snyder
    Brian F. Kabat
    Kari G. Rabe
    Susan L. Slager
    Sameer A. Parikh
    Avni Y. Joshi
    [J]. Journal of Hematopathology, 2020, 13 : 221 - 229
  • [9] Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies
    McNulty, Caitlin M.
    Isikwei, Emasenyie A.
    Shrestha, Pragya
    Snyder, Melissa R.
    Kabat, Brian F.
    Rabe, Kari G.
    Slager, Susan L.
    Parikh, Sameer A.
    Joshi, Avni Y.
    [J]. JOURNAL OF HEMATOPATHOLOGY, 2020, 13 (04) : 221 - 229
  • [10] RISK OF HEPATITIS B INFECTION REACTIVATION IN RHEUMATIC DISEASES PATIENTS TREATED WITH ANTI-CD20 THERAPY
    Fornaro, M.
    Lopalco, G.
    Venerito, V.
    Barone, M.
    Cantarini, L.
    Fabiani, C.
    Emmi, G.
    Silvestri, E.
    Lapadula, G.
    Lannone, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 583 - 583
12345